Correction to: Prognostic factors and nomogram development for adult diffuse large B-cell lymphoma: a single-center retrospective cohort study - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Erratum: Development of Prognostic Indicators and a Nomogram for Adult Diffuse Large B-Cell Lymphoma in a Retrospective Cohort from a Single Center

  • By

  • Jin Zhao

  • Jing Lian

  • Xiaolian Wen

  • Li Ma

  • Meijing Zheng

  • Liping Su

  • August 24, 2026

Share

Clinical Scorecard: Erratum: Development of Prognostic Indicators and a Nomogram for Adult Diffuse Large B-Cell Lymphoma in a Retrospective Cohort from a Single Center

At a Glance

CategoryDetail
ConditionDiffuse Large B-Cell Lymphoma
Key MechanismsPrognostic indicators and nomogram development
Target PopulationAdults with Diffuse Large B-Cell Lymphoma
Care SettingSingle-center retrospective cohort study

Key Highlights

  • Correction of ethics approval number from 2019-EC-55 to KY2025214
  • Focus on prognostic indicators for adult patients
  • Nomogram developed for clinical use

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Related Content